Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care

被引:6
|
作者
Corcoran, Anthony T. [1 ]
Smaldone, Marc C. [1 ]
Egleston, Brian L. [2 ]
Simhan, Jay [1 ]
Ginzburg, Serge [1 ]
Morgan, Todd M. [3 ]
Walton, John [1 ]
Chen, David Y. T. [1 ]
Viterbo, Rosalia [1 ]
Greenberg, Richard E. [1 ]
Uzzo, Robert G. [1 ]
Kutikov, Alexander [1 ]
机构
[1] Temple Univ, Sch Med, Fox Chase Canc Ctr, Dept Urol Oncol, Philadelphia, PA 19111 USA
[2] Temple Univ, Sch Med, Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA
[3] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
prostate carcinoma; screening; PSA; urological care; overdiagnosis; RADICAL PROSTATECTOMY; COMPETING RISK; URINE ASSAY; FOLLOW-UP; MORTALITY; NOMOGRAM; BIOPSY; PCA3; MEN;
D O I
10.1111/bju.12220
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate prostate cancer diagnosis rates and survival outcomes in patients receiving unrelated (non-prostate) urological care with those in patients receiving non-urological care. Materials and Methods We conducted a population-based study using the Surveillance Epidemiology and End Results (SEER) database to identify men who underwent surgical treatment of renal cell carcinoma (RCC; n = 18188) and colorectal carcinoma (CRC; n = 45093) between 1992 and 2008. Using SEER*stat software to estimate standardized incidence ratios (SIRs), we investigated rates of prostate cancer diagnosis in patients with RCC and patients with CRC. Adjusting for patient age, race and year of diagnosis on multivariate analysis, we used Cox and Fine and Gray proportional hazards regressions to evaluate overall and disease-specific survival endpoints. Results The observed incidence of prostate cancer was higher in both the patients with RCC and those with CRC: SIR = 1.36 (95% confidence interval [CI] 1.27-1.46) vs 1.06 (95% CI 1.02-1.11). Adjusted prostate cancer SIRs were 30% higher (P < 0.001) in patients with RCC. Overall (hazard ratio = 1.13, P < 0.001) and primary cancer-adjusted mortalities (sub-distribution Hazard Ratio (sHR) = 1.17, P < 0.001) were higher in patients with RCC with no significant difference in prostate cancer-specific mortality (sHR = 0.827, P = 0.391). Conclusion Rates of prostate cancer diagnosis were higher in patients with RCC (a cohort with unrelated urological cancer care) than in those with CRC. Despite higher overall mortality in patients with RCC, prostate cancer-specific survival was similar in both groups. Opportunities may exist to better target prostate cancer screening in patients who receive non-prostate-related urological care. Furthermore, urologists should not feel obligated to perform prostate-specific antigen screening for all patients receiving non-prostate-related urological care.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 50 条
  • [1] Can Non-Urological Doctors Play a Role in Early Prostate Cancer Detection?
    Yazici, Cenk M.
    Dogan, Cagri
    UROLOGY JOURNAL, 2014, 11 (02) : 1429 - 1434
  • [2] A meta-analysis of the effect of urological and non-urological medication on morphometric parameters of the prostate
    Sakalis, V
    Gkotsi, A.
    Mpolosis, N.
    Stratis, M.
    Charpidou, D.
    Tsafrakidis, P.
    Apostolidis, A.
    EUROPEAN UROLOGY, 2021, 79 : S50 - S51
  • [3] Are urological cancer patients receiving care in accordance with good practice?
    Brooks, A.
    Smith, D.
    Berry, M.
    Kneebone, A.
    Tynan, K.
    BJU INTERNATIONAL, 2006, 97 : 1 - 1
  • [4] Prediction of Stent Failure for Malignant Ureteral Obstruction in Non-Urological Cancer
    Heo, Ji Eun
    Jeon, Dae Young
    Lee, Jongsoo
    Han, Hyun Ho
    Jang, Won Sik
    YONSEI MEDICAL JOURNAL, 2023, 64 (11) : 665 - 669
  • [5] PROSTATE CANCER DIAGNOSIS IN PATIENTS RECEIVING UNRELATED UROLOGIC CARE: OVERDIAGNOSIS OR APPROPRIATE CARE?
    Corcoran, Anthony
    Smaldone, Marc
    Egleston, Brian
    Simhan, Jay
    Viterbo, Rosalia
    Chen, David
    Greenberg, Richard
    Uzzo, Robert
    Kutikov, Alexander
    JOURNAL OF UROLOGY, 2012, 187 (04): : E894 - E895
  • [6] COMPARISON OF PAEDIATRIC RENAL ALLOGRAFT SURVIVAL AND BIOPSY OUTCOMES BETWEEN PATIENTS WITH AN UNDERLYING UROLOGICAL OR NON-UROLOGICAL DIAGNOSIS: A SINGLE CENTRE RETROSPECTIVE ANALYSIS
    Kim, Ji Soo
    Marks, Stephen D.
    PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1960 - 1960
  • [7] Comparison of paediatric renal allograft survival and biopsy outcomes between patients with an underlying urological or non-urological diagnosis: A single centre retrospective analysis
    Kim, Ji Soo
    Desai, Divyesh
    Kessaris, Nicos
    Mushtaq, Imran
    Stojanovic, Jelena
    Marks, Stephen D.
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [8] Urological Oncology: Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2014, 191 (03): : 656 - 656
  • [9] Urological Oncology: Prostate Cancer
    不详
    JOURNAL OF UROLOGY, 2022, 207 (01): : 229 - 231
  • [10] Urological Oncology: Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2023, 209 (03): : 635 - 636